Sylvie Julien-Schraermeyer

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 3

Top Topics

Gold Nanoparticles

Optical Coherence Tomography

Top Venues

Oxidative medicine and cellular longevity

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Lei Xi, Marina Tikhonovich, Antje Biesemeier, Sylvie Julien-Schraermeyer, Ulrich Schraermeyer, Alexander V Tschulakow
Pigment Epithelium-Derived Factor Protects Retinal Neural Cells and Prevents Pathological Angiogenesis in an Ex Vivo Ischemia Model. Oxidative medicine and cellular longevity 2022 (2022)
Sylvie Julien-Schraermeyer, Barbara Illing, Alexander Tschulakow, Tatjana Taubitz, Jamil Guezguez, Michael Burnet, Ulrich Schraermeyer
Penetration, distribution, and elimination of remofuscin/soraprazan in Stargardt mouse eyes following a single intravitreal injection using pharmacokinetics and transmission electron microscopic autoradiography: Implication for the local treatment of Stargardt's disease and dry age-related macular degeneration. Pharmacology research & perspectives 8 (6) (2021)
Alexander V Tschulakow, Ulrich Schraermeyer, H Peter Rodemann, Sylvie Julien-Schraermeyer
Establishment of a novel retinoblastoma (Rb) nude mouse model by intravitreal injection of human Rb Y79 cells - comparison of in vivo analysis versus histological follow up. Biology open 5 (11) (2016)